Pfizer Notes Doctor Decisions In Appeal Of $142M RICO Award
Pfizer Inc. argued to the First Circuit on Wednesday that physicians' independent decisions to prescribe pain drug Neurontin for off-label uses should take the drugmaker off the hook for a $142...To view the full article, register now.
Already a subscriber? Click here to view full article